Ranitidine 是一种选择性的，具有口服活性的组胺 H2 受体拮抗剂，IC50为 3.3 μM。它还一种是CYP2C19和CYP2C9的弱抑制剂，可抑制胃液分泌。

Ranitidine is a non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers.

66357-35-5

C13H22N4O3S

314.4

Ranitidin;雷尼替丁;HSDB 3925

DMSO:57 mg/mL(181.3 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years